Navigation Links
Government Allot More Funds for Revised TB Program

New Delhi: India witnesses nearly 1.8 million tuberculosis cases every year and to tackle the health menace the government// has cleared Rs. 11.56 billion for the Revised National Tuberculosis Program (RNTCP)-Phase II.

As per government estimates, nearly 40 percent of the population is infected with TB bacillus but only 10 percent break down to full-blown disease in their lifetime, Minister of State for Health P. Lakshmi said Friday.

"The RNTCP Phase-II of the World Bank Project has been approved by the government for the period October 2006 to September 2011 for a total outlay of Rs. 11.56 billion. This includes credit of Rs. 7.65 billion from the World Bank and a grant of Rs. 1.99 billion for commodity assistance of anti-TB drugs from the Department of International Development (DFID)," Lakshmi informed Rajya Sabha.

She said the RNTCP, popularly known as DOTS program, was introduced in the country in 1997 in a phased manner with an objective to achieve a cure rate of 85 percent of new sputum positive cases and to detect at least 70 percent of such cases. The entire country was covered by March 2006.

Till date, 6.7 million patients have received DOTS treatment averting more than 1.22 million deaths.

"In 2006 alone, 1.4 million cases were placed under DOTS, more than in any country in a single year. The overall performance of RNTCP has been excellent with cure completion rate consistently above 85 percent and death rate reduced to less than 5 percent," the minister said.

"The second phase of RNTCP will consolidate, maintain and further improve the achievements of first phase," she added.

Under the second phase, the government would strive for implementation of DOTS-Plus for multi-drug resistant TB in a much broader way. Procurement and distribution of paediatric drug boxes for improved care of children will also start soon.

The program would also encourage participation
'"/>




Page: 1 2

Related medicine news :

1. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
2. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
3. Tanzanian Government Sanctions $20 Million For AIDS Arug
4. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
5. Indian Government warns Gujarat regarding possibility of bird flu
6. Indian Government Sets Up Task Force For Avian flu
7. Delhi Government To Interlink All Major Hospitals Through e-Governance
8. Kerala Government is in High Alert for Bird Flu
9. Philippines Government prepares to counter bird flu
10. Government Takes Tough Stand Against Falling Sex Ratio
11. Avian Influenza: Government to set up expert committee
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ady option that can work like a magic potion to co...sode of stroke or cerebro// vascular accident(CVA)...University ,who conducted a study on mice, reveal... found commonly in the skin of red grapes, adminis...
...t overweight youngsters lose weight by concentrati...d are likely to make them// gorge even more, accor...y are no more motivated to change their eating hab...y with their appearance. Rather the researchers ...
...tudy conducted by epidemiologists of Dupont & Co.,...rtality risk among the workers at// DuPont who ar... the key component of the material Teflon. The st...ompany definitely reveals lower mortality rates t...
...kungunya fever in Kerala will not affect the state...iyeri Balakrishnan said Tuesday. "As the World He... saying that the fever widespread here is not chik... have been no reports of cancellation by tourists ...
Other Medicine News:Health News:Obese Kids Unmotivated byWeight Loss campaigns 2
(Date:9/4/2008)...RICH, Switzerland, September 4 /- Axe...trial to assess the safety and tolerability,of a n...vere pulmonary,infection in cystic fibrosis patien...apeutic agent to be delivered directly to the site...pare the effects of two,different doses of the new...
(Date:9/4/2008)...mg cohort demonstrates potent antiviral activity a...profile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-...: IDIX ), a biopharmaceutical company engaged,in ...atment of human viral,and other infectious disease...-of-concept study evaluating IDX899, a non-nucleos...
(Date:9/4/2008)...a Announcements Remain on Schedule with Two Abstra...cal Data Release in November 2008, BRIDGEWATER, N...als,Inc., a specialty pharmaceutical company focu...ic disease, today announced the appointment of,Pet...rectors., Peter Garrambone,s career includes more...
(Date:9/3/2008)... says: Wrong Question Asked. Wrong Children Studie... /PRNewswire-USNewswire/ -- A Centers for Disease,...claims there is no link,between the MMR vaccine an...ys this study does nothing to dispel the growing p... raises several questions concerning design,and me...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2Programmed death boosts business 3232 1Programmed death boosts business 3232 2Genomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference 18761 1Genomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference 18761 2VIA Pharmaceuticals to Present at Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5223 1Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine 28R 29 28VNP40101M 29 in Combination with Cytarabine 2011 1Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine 28R 29 28VNP40101M 29 in Combination with Cytarabine 2011 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine 28R 29 28VNP40101M 29 in Combination with Cytarabine 2011 3
...E)--Jun 20, 2007 - Materia, Inc., a,catalyst techn...s,metathesis platform to Eisai Co., Ltd., a leadin... discovery and development.,The non-exclusive lice..., and patent pharmaceutical compounds and related ...ated intellectual property., Metathesis catalysts ...
...ewswire-USNewswire/ -- The,following statement may...n for the Advancement of Medical Research (CAMR): ...sident Bush once,again used the stroke of his veto...ific and medical research, as well as endanger,the...le. His,executive order directing NIH to continue ...
Other Medicine Technology:Materia Licenses Metathesis Catalyst Platform to Eisai 2President Bush Ignores America's Plea for Support of Stem Cell,Research 2
Rhoton Curettes, titanium, length 191 mm, straight.
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated.
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Medicine Products: